Acupuncture for Cancer-Related Fatigue in Patients With Breast Cancer: A Pragmatic Randomized Controlled Trial
Molassiotis et al. · Journal of Clinical Oncology · 2012
Evidence Level
STRONGOBJECTIVE
Evaluate the efficacy of acupuncture in treating cancer-related fatigue in women with breast cancer
WHO
302 women with breast cancer who had completed chemotherapy and presented with moderate to severe fatigue
DURATION
6 weeks of treatment with 1 weekly acupuncture session
POINTS
3 pairs of points: ST-36, SP-6, and LI-4 (bilaterally), with alternatives GB-34 and SP-9
🔬 Study Design
Acupuncture + usual care
n=227
6 weekly 20-minute acupuncture sessions + educational leaflet
Enhanced usual care
n=75
Educational leaflet on fatigue and management
📊 Results in numbers
Reduction in general fatigue (MFI)
Statistical significance
Reduction in physical fatigue
Reduction in mental fatigue
Complete data rate
Percentage highlights
📊 Outcome Comparison
General Fatigue (MFI) - week 6
This study showed that acupuncture can be an effective option for reducing persistent fatigue after breast cancer treatment. Women who received 6 weekly acupuncture sessions reported significant improvement in fatigue, anxiety, depression, and quality of life compared with the control group.
Article summary
Plain-language narrative summary
This study represents an important milestone in research on acupuncture for cancer-related fatigue, being the first large-scale multicenter randomized clinical trial to investigate this application. Cancer-related fatigue (CRF) is a significant problem affecting up to 40% of disease-free patients with breast cancer, causing substantial impact on quality of life even years after treatment.
The investigators conducted a pragmatic randomized controlled trial involving 302 women with breast cancer who had completed adjuvant chemotherapy at least 1 month and up to 5 years earlier, and who presented with moderate to severe fatigue (score ≥5 on a 0-10 scale). The pragmatic design was chosen to better reflect real clinical practice, focusing on effectiveness rather than efficacy.
Participants were randomized in a 3:1 ratio to the acupuncture group (227) versus control (75). The intervention group received 6 weekly acupuncture sessions of 20 minutes each, using a standardized protocol with bilateral needling of three pairs of points: ST-36 (Zusanli), SP-6 (Sanyinjiao), and LI-4 (Hegu), with alternative points GB-34 and SP-9 when necessary. Treatment was performed by 12 qualified acupuncturists with a minimum of 2 years of clinical experience.
The primary outcome was general fatigue measured by the Multidimensional Fatigue Inventory (MFI) at week 6. Secondary outcomes included other dimensions of fatigue (physical, mental, activity, motivation), anxiety and depression (HADS), and quality of life (FACT-B).
Results were highly significant. The mean difference in the General Fatigue score between groups was -3.11 points (95% CI: -3.97 to -2.25; p < 0.001), favoring the acupuncture group. All other dimensions of fatigue also improved significantly: physical fatigue (-2.36), mental fatigue (-1.94), reduced activity (-2.29), and reduced motivation (-2.02), all with p < 0.001.
Notably, acupuncture also provided benefits in anxiety (-1.83) and depression (-2.13), both significant at p < 0.001, in addition to improvements in all quality-of-life domains: physical well-being (+3.30), functional (+3.57), emotional (+1.93), and social (+1.05).
The clinical implications are substantial. This study provides robust evidence that acupuncture can be an effective intervention for CRF management, improving not only fatigue but also the psychological well-being and quality of life of patients. The protocol used is replicable and clinically feasible, using well-established points in traditional Chinese medicine (中醫) for energetic tonification.
However, some limitations should be considered. The absence of a sham-acupuncture group makes it impossible to distinguish specific effects from placebo, although the authors argue convincingly about the methodologic and ethical limitations of sham controls. The rate of missing data was 18.5%, within the expected range but with a difference between groups (20.3% acupuncture vs 13.3% control). The population was self-selected, limiting the generalizability of the findings.
Strengths
- 1First large multicenter study on acupuncture for cancer-related fatigue
- 2Robust sample size with high methodologic quality
- 3Standardized and replicable acupuncture protocol
- 4Consistent results across multiple outcomes
- 5Pragmatic design reflects real clinical practice
Limitations
- 1Absence of a sham control group makes it impossible to distinguish specific effects from placebo
- 2Missing data rate differed between groups (20.3% vs 13.3%)
- 3Self-selected population may limit generalizability
- 4Inability to blind participants
- 5Lack of data on long-term sustainability of effects
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
Cancer-related fatigue remains one of the most debilitating and underaddressed symptoms in oncology, affecting a substantial proportion of breast cancer survivors even after treatment has ended. This work by Molassiotis and colleagues, published in the Journal of Clinical Oncology, provides effectiveness evidence on a scale the field had not previously seen — 302 patients, multicenter design, reproducible protocol. For the clinician working in a supportive oncology clinic, this concretely changes the conversation with the patient who presents complaining of persistent exhaustion months after adjuvant chemotherapy. The protocol used — bilateral ST-36, SP-6, and LI-4, six weekly sessions — is accessible in services that have a medical acupuncturist available, and the observed improvement encompassed fatigue, anxiety, depression, and quality of life simultaneously, which represents a multidimensional therapeutic gain difficult to achieve with pharmacologic interventions alone.
▸ Notable Findings
The magnitude of the reduction in general fatigue by the MFI — 3.11 points in favor of acupuncture, with p < 0.001 — is clinically meaningful on a scale sensitive to real functional changes. What stands out, however, is the breadth of the effect: all five dimensions of the MFI improved significantly, including mental fatigue and reduced motivation, domains that frequently resist exclusively physical approaches. The impact on anxiety and depression — with reductions of 1.83 and 2.13 points, respectively, on the HADS — suggests that the benefit is not limited to fatigue as an isolated phenomenon, but reaches the emotional substrate that often sustains it. The functional well-being subscale of the FACT-B gained 3.57 points, and the physical 3.30 points, indicating that the subjective improvement in fatigue translated into measurable functional gains. The pragmatic design, deliberately chosen, lends these numbers an ecological validity that controlled efficacy studies rarely manage to offer.
▸ From My Experience
In my practice in the Acupuncture Group of the Pain Center of HC-FMUSP, persistent cancer-related fatigue is a frequent complaint and, I acknowledge, for a long time it was treated with therapeutic skepticism — as if it were an inevitable consequence about which little could be done. What I have observed over the years is that patients with this profile — breast cancer survivors, moderate to severe fatigue, depressed mood — usually respond by the third or fourth session with reports of improved sleep patterns and a sense of greater morning energy. The combination of ST-36 and SP-6 used in the study corresponds to what we classically employ for tonification of Spleen Qi and Kidney, patterns we frequently identify in this group. I typically conduct eight to ten sessions in the acute phase, followed by monthly maintenance. I always include guidance on the progressive resumption of physical activity and, when there is a marked anxiety component, supportive psychotherapy. The profile that responds best, in my experience, is precisely that of this sample: established fatigue, no active disease, motivated for complementary treatment.
Full original article
Read the full scientific study
Journal of Clinical Oncology · 2012
DOI: 10.1200/JCO.2012.41.6222
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories